Crown Castle International ($CCI.US) Q 2018: Positioned well for 2019

Crown Castle International Corp. (CCI) had another strong quarter, outpacing guidance and expectations for revenue and AFFO per share. CCI introduced slightly higher guidance for revenues and adjusted EBITDA for the remainder of the calendar year. The company increased its annual dividend to $4.50, a 7% increase YoY. Growth in the towers space continues to be driven by consumer demand for data which leads to investment by mobile carriers. Within the space, CCI is best positioned to take care of carrier needs across towers and small cell/fiber. CCI’s investment in small cells and fiber are performing better than expected and the company’s margins should continue to improve as they increase colocation on their newly developed small cells.

Current Price: $107 TTM Return: 11.1%

Target Price: $125 Position Size: 2%

Continue reading “Crown Castle International ($CCI.US) Q 2018: Positioned well for 2019”

JNJ 3Q18 earnings results

Key Takeaways:

Current Price: $136 Price Target: $163

Position size: 2.67% 1-Year Performance: -1.6%

JNJ reported 3Q18 earnings results that beat consensus thanks to strong Pharma sales again (+8.2% organic). In Pharma, the growth of Stelara, Zytiga, Imbruvica and Tremfya help offset Remicade’s decline due to the generics competition. It is reassuring to see that JNJ’s portfolio of drugs is vast enough to offset the erosion of Remicade. JNJ doesn’t expect a big change in drug pricing in its portfolio in 2019, seeing continued pricing pressure in categories with high competition (diabetes, immunology…). Medical Devices grew an anemic +1.7% organic, similar to last quarter and for the same reasons (weakness in diabetes –pump discontinuation- and Ortho –share decline & pricing pressure). The company expects some innovation to help turn the business in the right direction, and is open to small tuck-in M&A and/or a bigger asset purchase. Their Consumer segment is finally showing positive growth +4.9% thanks to the relaunch of the baby care, women’s health performance, oral care rebound, Beauty and OTC drugs. Guidance for organic sales growth in 2018 was raised by 50-100bps, and operational revenue to $81-81.4B (from $80.5-81.3B), and EPS guidance was lifted by 4 cents. Continue reading “JNJ 3Q18 earnings results”

Test posting please ignore!

As a reminder, a key function of the PBM is to leverage scale and competition to reduce drug costs for clients. PBM keep up to 10% of the “saving”, although CVS mentioned being closer to 5%. Per Goldman Sachs, the rebates business represents a mid-single digit % of its EBITDA. Below is Goldman’s calculation:

 

cid:<a href=image001.png@01D41F46.8B1A85D0“>

·         Full year EPS and SSS guidance raised. Full year EPS guidance is $4.12 at the midpoint vs $4.07 previously (excluding benefit from a lower tax rate).

·         SSS now expected to be +3-4% vs +1-2% previously (in their 40+ yr. history they’ve had only 1 year of negative SSS).

·         They again made a point about their ability to attract a younger customer to validate the sustainability of their business model. “We are particularly pleased that we have been attracting a significant share of millennial and Gen Z shoppers among our new customers”…”the majority of new customers at Marmaxx, are these younger customers which indeed bodes very well for our future.” There were several minutes of discussion around this, so they must be getting a lot of questions from investors.

·         Merchandise margin was down, but would have been up significantly excluding freight costs – i.e. they are not “buying” this better growth with deeper discounts. Inventory grew in line with sales, a positive indicator for future merchandise margins.

 

[more]

 

 

QUARTER ENDED PAYMENT VOLUME (billions)

 

QUARTER ENDED TRANSACTIONS (millions)

Valuation:

·         FCF for the quarter was $3.5B and YTD is $8.7B. Trading at a 4% FCF yield.

·         They’ve returned most of their YTD FCF to shareholders through dividends ($1.5B) and buybacks ($5.55B). They have $5.8 billion remaining for share repurchase.

·         For revenue beats: REITs, Industrials and utilities have had the highest % surprise.

·         According to FactSet, the market is rewarding upside earnings surprises less than average and punishing downside earnings surprises more than average.

·         For all of 2018, analysts are projecting earnings growth of 19.5% and revenue growth of 7.2%.

·         Forward P/E Ratio is 16x – it was 16.4x at the beginning of the year. The 5-year average is 16.1x and the 10-Year average is 14.3x.

·          

·         [more]

·        

·          

·         increased household formation. Rising prices tend to increase remodeling activity and spur new housing starts both of which benefit SHW.  Historically, architectural paints is a good leading indicator of industrial paint demand, which means the overall LT demand picture for SHW looks robust. In addition to this, their margins will improve as they increasingly pass on rising input costs and they realize synergies from the Valspar acquisition.

·          

·        

 

 

John R. Ingram CFA

Managing Director

Asset Allocation and Research

 

Direct: 617.226.0021

Fax: 617.523.8118

 

Crestwood Advisors

One Liberty Square

Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

 

By the Numbers – Client Education & Wage Increases

Attached is this week’s version of “By the Numbers” from MFS. The two facts below touch upon the average investor’s understanding of equity markets and a clarification of total employee compensation.

“48% of 2,000 American adults surveyed in August 2018 thought the US stock market had been flat over the last 10 years. Another 18% of the 2,000 folks surveyed thought the US stock market had declined over the last 10 years” (source: Betterment).

“For every $1 spent for wages and salaries in the private sector, employers spend an additional 44 cents on benefits. Average compensation is $23.78 per hour while the cost of benefits averages an additional $10.41 per hour” (source: Bureau of Labor Statistics).

What I find most interesting about the 48% stat is the source, Betterment. This is one of the larger unaffiliated Robo-Advisors showing that investors are often unaware of what is taking place in the market. This simple client education is something that can be provided by a full service Investment Advisor much more effectively than a web-based robo platform.

Peter Malone, CFA

Research Analyst

Direct: 617.226.0030

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square

Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

BTN 9-24-18.pdf

AAPL: Impact of latest potential tariff and new phones

Updating my last note regarding Apple and tariffs. The latest $200B of tariffs set to take effect on Monday initially were going to impact Apple Watches and Airpods (less than 5% of rev), that changed with the final release. Neither product will be impacted by this round of tariffs.

From: Sarah Kanwal
Sent: Wednesday, September 12, 2018 12:58 PM
To:
Subject: AAPL: Impact of latest potential tariff and new phones

Today Apple is announcing their new product lineup at a 1pm launch event – 3 new phones are expected. Analyst expectations around the new device launches are ratcheting up, with some increasing price targets. This is despite developments on the tariff front that are looking more threatening to Apple. Last week the White House took comments on the latest round of impending tariffs (up to 25% tariffs on $200 billion in Chinese goods). This would be on top the $50B of Chinese exports already hit with 25% duties (which didn’t effect Apple’s products). Apple submitted a comment letter indicating the $200B round of tariffs would affect the Apple Watch, AirPods, MacMini and Apple Pencil. These items account for <5% of Apple’s revenue. So, not a big hit yet. In the letter Apple said, “tariffs increase the cost of our U.S. operations, divert our resources and disadvantage Apple compared to foreign competitors.” The letter also reiterated a lot of what Tim Cook said on Apple’s last earnings call – essentially that tariffs are a tax on the consumer and that they can have broad unintended economic consequences.

Next Trump threatened another $267B in tariffs and suggested Apple should move their manufacturing to the US. In June, the Trump administration said they would not impose tariffs on iPhones, but this next $267B suggests otherwise as that basically implies a duty on all goods imported from China. This could be used to influence Apple to move some manufacturing to the US. Most of Apple’s assembly occurs in China (only about 5% of Apple’s manufacturing takes place in the US) and to shift this would take a lot of money and time. Labor supply in the US would also be a limiting factor. Trump hinted at tax incentives that would help offset the cost of doing this. If more assembly moved to the US, it seems likely that most of the higher labor costs would be passed on to consumers via higher prices. Most estimate price increases in the 15-20% range to offset higher labor. While Apple has a lot of buyer power, their suppliers generally operate on thin margins making it more difficult to push some of this higher cost burden to them. This is illustrated by the chart below (from The Economist) of Apple’s 42 biggest suppliers (representing 75% of Apple supplier gross profits). Apple and the chip suppliers occupy the high value added, high margin portion of this value chain and command 90% of the profit pool. Interestingly, this disparity also illustrates potential risks that come with their complex multinational supply chain. That profit concentration could lead to structurally weaker participants that may have a hard time weathering these trade tensions. The not Apple and not chip (i.e. not US) portion of production has most of the employees and requires lots of capital for PP&E and inventory, but they capture only a small sliver of the profits. Because of this, there may be some financially weaker players in the supply chain. Combining low margins and capital intensity (likely have debt to service) could put some suppliers at risk if costs rise or business from Apple slows as trade issues get sorted out.

Sarah Kanwal

Equity Analyst, Director

Direct: 617.226.0022

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square, Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

EU Copyright Directive

· The EU is on a path to create copyright laws aimed at helping publishers of content (e.g. journalists, musicians etc.) get a bigger piece of ad revenues that go to companies like Google and Facebook.

· The EU parliament voted in favor of the directive a couple days ago, but there are several more steps for this to pass.

· The new rules would give publishers the right to ask for paid licenses when a platform shares their stories (i.e. Google News) or video clips. Some are calling it a “link tax." The rules would also put the obligation on platforms to identify what is copyrighted by making them liable for copyright infringement.

· The implications aren’t entirely clear yet. For example, the rules would apply to “commercial platforms” but it’s not clear whether that applies to blogs etc., which would widen the impact.

· Other countries like Spain and Germany tried similar rules in the past and they failed. Google’s response was either to shut down Google News or just remove any news sources that wouldn’t give it free access…which meant traffic to those sites collapsed.

· The regulation might actually reinforce the dominance of the strongest players. The cost burden of this regulation would be easier for large firms like Google to absorb as it would require firms to build technology to identify and filter copyrighted content. Thus it might have the unintended consequence of strengthening Google (and other platform giants) relative to smaller firms/startups. In fact, Google already largely complies with these rules on YouTube with their “Content ID” filter.

· Opponents also say that complying with these rules would limit the free access of information that the internet is designed to offer.

· If this directive keeps progressing their will likely be more vocal industry resistance, as many who have been critical of the big tech firms don’t support it. For example, Tim Berners-Lee (inventor of the world wide web), who has spoken widely about the risks of Google’s and Facebook’s dominance, is ardently against these potential regulations.

Sarah Kanwal

Equity Analyst, Director

Direct: 617.226.0022

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square, Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

Apple New Devices

Yesterday Apple held an event introducing their latest devices. A few big takeaways…

1. Higher iPhone price points and a wider price point range.

a. They have 3 new phones – will range in price from $749-$1449. XR, XS and XS Max. iPhone 7 price dropped to $449.

b. The iPhone XS Max – most expensive of the 3 (starts at $1099) and largest (6.5”)

c. Overall this should help ASPs – this is key because ASPs are driving their growth right now as units are flattish.

d. There’s some concern the cheapest of the 3 new models might be gross margin dilutive. Changes are evolutionary, but I think likely to drive enough uptake of more expensive models to offset any margin dilution from cheaper ones.

e. Way more memory. Most expensive XS models will have over half a terabyte of memory. That’s enough for 200k photos.

f. A12 Bionic Chip – “the smartest, most powerful chip ever in a smartphone.”

i. Industry’s 1st 7nm chip (Huawei has a 7nm chip announced too, but Apple’s ships first)

ii. Up to 50% faster than the A11.

iii. Enables more powerful apps…like augmented reality gaming.

g. All use face ID, no home buttons.

h. Waterproof to 2 meters, up to 30 minutes.

i. Camera is again improved.

2. New functionalities of the Apple Watch

a. Fall detection – if the watch detects a fall, it readies for a one-swipe 911 call. If you’re motionless for longer than a minute, it will automatically call 911 and send an alert to your emergency contact list.

b. New heart monitoring capabilities – can detect atrial fibrillation and perform an electrocardiogram. The president of the American Heart Association got on stage and said capturing meaningful real time data this way “will change the way medicine is practiced.” FDA clearance has been received on this.

c. 30% larger display (40mm & 44mm). New price points: $279-$499

3. Dual SIM

a. Makes it possible to have 2 phone numbers on one phone.

b. This is expected to be in high demand in international markets, especially China.

c. Accomplished by adding an eSIM card – basically a virtual SIM instead of a physical one (some international markets are 2 physical SIMs).

d. eSIMs may increase carrier churn and lead to more plan deflation because they make switching carriers easier, leading to more price competition.

4. Sustainability Presentation

a. Apple’s head of Environmental and Social issues got on stage and talked about their initiatives with renewable energy and using recycled parts.

b. For example, the logic board is now made of recycled tin and the cover has glass that’s 32% bio-based plastic.

Sarah Kanwal

Equity Analyst, Director

Direct: 617.226.0022

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square, Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

AAPL: Impact of latest potential tariff and new phones

Today Apple is announcing their new product lineup at a 1pm launch event – 3 new phones are expected. Analyst expectations around the new device launches are ratcheting up, with some increasing price targets. This is despite developments on the tariff front that are looking more threatening to Apple. Last week the White House took comments on the latest round of impending tariffs (up to 25% tariffs on $200 billion in Chinese goods). This would be on top the $50B of Chinese exports already hit with 25% duties (which didn’t effect Apple’s products). Apple submitted a comment letter indicating the $200B round of tariffs would affect the Apple Watch, AirPods, MacMini and Apple Pencil. These items account for <5% of Apple’s revenue. So, not a big hit yet. In the letter Apple said, “tariffs increase the cost of our U.S. operations, divert our resources and disadvantage Apple compared to foreign competitors.” The letter also reiterated a lot of what Tim Cook said on Apple’s last earnings call – essentially that tariffs are a tax on the consumer and that they can have broad unintended economic consequences.

Next Trump threatened another $267B in tariffs and suggested Apple should move their manufacturing to the US. In June, the Trump administration said they would not impose tariffs on iPhones, but this next $267B suggests otherwise as that basically implies a duty on all goods imported from China. This could be used to influence Apple to move some manufacturing to the US. Most of Apple’s assembly occurs in China (only about 5% of Apple’s manufacturing takes place in the US) and to shift this would take a lot of money and time. Labor supply in the US would also be a limiting factor. Trump hinted at tax incentives that would help offset the cost of doing this. If more assembly moved to the US, it seems likely that most of the higher labor costs would be passed on to consumers via higher prices. Most estimate price increases in the 15-20% range to offset higher labor. While Apple has a lot of buyer power, their suppliers generally operate on thin margins making it more difficult to push some of this higher cost burden to them. This is illustrated by the chart below from The Economist of Apple’s 42 biggest suppliers (representing 75% of Apple supplier gross profits). Apple and the chip suppliers occupy the high value added, high margin portion of this value chain and command 90% of the profit pool. Interestingly, this disparity also illustrates potential risks that come with their complex multinational supply chain. That profit concentration could lead to structurally weaker participants that may have a hard time weathering these trade tensions. The not Apple and not chip (i.e. not US) portion of production has most of the employees and requires lots of capital for PP&E and inventory, but they capture only a small sliver of the profits. Because of this, there may be some financially weaker players in the supply chain. Combining low margins and capital intensity (likely have debt to service) could put some suppliers at risk if costs rise or business from Apple slows as trade issues get sorted out.

Sarah Kanwal

Equity Analyst, Director

Direct: 617.226.0022

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square, Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

By the Numbers – Best Trading Days

Good Morning,

Attached is this week’s “By the Numbers” piece from MFS. The two statistics below reiterate (again) why it makes sense for clients to remain invested.

“The total return of the S&P 500 stock index over the last 10 calendar years (2008-2017) is +126.0% (total return). The 10 best trading days during the 10 years (i.e., 10 days out of 2,518 trading days) produced an +97.9% gain. Thus, 10 trading days over the last 10 years were responsible for 78% of the index’s total return, i.e., less than ½ of 1% of the trading days drove 78% of the index’s return”

“The 3 best gain days (by percentage) for the S&P 500 in the last 68 years (i.e., dating back to January 1950) all occurred during the month of October”

As always, the idea is not to use technicals to time when or how to be invested but, rather, to maintain a diversified portfolio over the long term that does not miss market upswings at the cost of preventing any temporary selloffs.

Peter Malone, CFA

Research Analyst

Direct: 617.226.0030

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square

Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

PLEASE NOTE!

We moved! Please note our new location above!

BTN 9-4-18.pdf

Strategas – Wealth Management Industry

This is a very good read from Strategas that broadly discusses the landscape of wealth management. Here is an excerpt that gives an outline of the paper:

“In one way, what was old is new again. The importance of the fiduciary and the provision of holistic, relationship-driven, risk-based advisory services has moved firms to again covet the same affluent clients that bank trust departments worked for 50 years ago – there are just so many more of them. We will explore the re-emergence of the fiduciary and ponder some of the implications on the business.”

Peter Malone, CFA

Research Analyst

Direct: 617.226.0030

Fax: 617.523.8118

Crestwood Advisors

One Liberty Square

Suite 500

Boston, MA 02109

www.crestwoodadvisors.com

PLEASE NOTE!

We moved! Please note our new location above!

Strategas – Summer Essay Series.pdf